Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--May 16, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 2019 UBS Global
View HTML
Toggle Summary Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year
Commenced Pod Production at U.S. Manufacturing Facility and Initiated Full U.S. Commercial Launch of Omnipod DASH ™ ACTON, Mass. --(BUSINESS WIRE)--May 2, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility in Acton, MA
Over $200 Million Investment in Massachusetts Creates Hundreds of Local Manufacturing Jobs and a Launchpad for New Product Innovation ACTON, Mass. --(BUSINESS WIRE)--May 2, 2019-- Insulet Corporation  (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod
View HTML
Toggle Summary Insulet to Announce First Quarter 2019 Financial Results on May 2, 2019
ACTON, Mass. --(BUSINESS WIRE)--Apr. 4, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter of 2019 on 
View HTML
Toggle Summary Insulet Reports Fourth Quarter 2018 Revenue of $164.9 Million, Up 26% Year-Over-Year, and Full Year 2018 Revenue of $563.8 Million, Up 22%
ACTON, Mass. --(BUSINESS WIRE)--Feb. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for the three months and full year
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Feb. 19, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences: The Raymond James
View HTML
Toggle Summary Insulet Appoints Corinne Nevinny to Board of Directors
ACTON, Mass. --(BUSINESS WIRE)--Jan. 28, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Corinne Nevinny has been appointed to the Company’s
View HTML
Toggle Summary Insulet to Announce Fourth Quarter and Full Year 2018 Financial Results on February 25, 2019
ACTON, Mass. --(BUSINESS WIRE)--Jan. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full
View HTML
Toggle Summary Insulet Appoints Wayde McMillan Chief Financial Officer
ACTON, Mass. --(BUSINESS WIRE)--Jan. 7, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Wayde McMillan has been appointed Executive Vice
View HTML
Toggle Summary Insulet to Present at the 37th Annual J.P. Morgan Healthcare Conference
ACTON, Mass. --(BUSINESS WIRE)--Dec. 18, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 37th Annual J.P.
View HTML
Toggle Summary Insulet’s Omnipod DASH™ Insulin Management System Receives ISO 27001 Certification for Information Security
The Only Insulin Pump to Receive Both ISO 27001 and DTSec Certifications BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 20, 2018-- Insulet Corporation  (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 19, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 30th Annual
View HTML
Toggle Summary Insulet Collaborates with Samsung to Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System
Incorporates Best-In-Class Cyber-Security Protocols and Mobile App Controlled Omnipod BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 7, 2018-- Insulet Corporation  (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod
View HTML
Toggle Summary Insulet Raises Awareness for National Diabetes Awareness Month
Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 5, 2018-- Insulet Corporation  (NASDAQ:PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points
Achieved Both Positive Operating and Net Income for the First Time in Insulet's History BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 1, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
View HTML